Submissions

Login or Register to make a submission.

Submission Preparation Checklist

As part of the submission process, authors are required to check off their submission's compliance with all of the following items, and submissions may be returned to authors that do not adhere to these guidelines.
  • The submission file is in OpenOffice, Microsoft Word, or RTF document file format.
  • Where available, URLs for the references have been provided.
  • The text is single-spaced; uses a 12-point font; employs italics, rather than underlining (except with URL addresses); and all illustrations, figures, and tables are placed within the text at the appropriate points, rather than at the end.
  • The text adheres to the stylistic and bibliographic requirements outlined in the Author Guidelines.

Author Guidelines

Instructions for abstract submission

Author eligibility

  1. Abstract presenters should meet the requirements of authorship (ICMJE criteria) for the work they wish to present
  2. Only abstracts that fall within the conference theme and subthemes will be accepted
  3. Authors are required to submit original work that has not been presented in other conferences or published in scientific journals
    • In selected circumstances, published work can be accepted provided the author justifies its relevance for the conference and adequately modifies the submission to attain adequate originality
  4. Authors must declare any relevant conflicts of interest for their submission
  5. If authors wish to submit a full-length manuscript for consideration for publication to the Kabarak Journal of Medical, Pharmaceutical and Allied Sciences, they can do so via this link https://journals.kabarak.ac.ke/index.php/kjmps

Abstract structure

  1. The abstract should contain no more than 400 words
  2. The abstract should have the following sections:
    • Conference subtheme
    • Title
    • Authors – A list of authors and their affiliations should be provided and the name of the presenting author should be in bold
    • Declaration of originality and conflict of interest statement
    • Background
    • Objectives
    • Methods
    • Results / Expected outcomes (not required for proposals)
    • Discussion

Abstract review process

  1. Each abstract will be peer-reviewed by two independent experts
  2. An abstract will be accepted if it meets the minimum submission requirements and is scientifically sound
  3. Authors may be advised to make modifications to their submissions if they do not meet submission requirements or if there are minor scientific deficiencies
  4. Abstracts that are not scientifically sound will not be accepted for presentation
  5. Authors will be notified of the status of their submission.

Digital Drug Discovery, Optimization, and Predictive Modelling in Clinical Trials

Papers should explore the application of computational tools, artificial intelligence, and predictive analytics in drug discovery, clinical trial design, and pharmaceutical optimization.

Advanced Drug Discovery Systems

Submissions may focus on emerging pharmaceutical technologies, novel drug delivery systems, molecular innovations, and new approaches to therapeutic development.

Pharmaceutical Manufacturing and Scale-Up

Studies addressing modern pharmaceutical production techniques, process optimization, industrial scale-up of drug formulations, automation in manufacturing, and strategies to improve efficiency, quality, and regulatory compliance in pharmaceutical production.

Quality by Design (QbD)

Papers discussing systematic approaches to pharmaceutical development that emphasize product and process understanding, risk management, design space, and quality assurance to ensure consistent product quality.

Regulatory Science

Research examining regulatory frameworks, policy development, drug approval processes, pharmacovigilance, compliance with international regulatory standards, and strategies for ensuring safety, quality, and efficacy of pharmaceutical products.

Green Pharmaceutics

Papers focusing on environmentally sustainable practices in pharmaceutical research, development, and manufacturing, including green chemistry, eco-friendly formulations, waste reduction, and sustainable sourcing of pharmaceutical ingredients.

Cosmeceuticals and Nutraceutical Integration

Research exploring the development, formulation, efficacy, and regulation of cosmeceuticals and nutraceuticals, including natural product-based therapies, functional foods, and the intersection between pharmaceuticals, cosmetics, and nutrition.

Patient-Centered Innovation and Treatment

Studies highlighting innovations that improve patient outcomes, adherence, accessibility, and personalized medicine approaches, including patient-focused formulation design, digital health solutions, and community-based pharmaceutical care models.

Privacy Statement

The names and email addresses entered in this conference site will be used exclusively for the stated purposes of this conference and will not be made available for any other purpose or to any other party.